Alembic Pharmaceuticals Limited announced during the first half of the trading session (at around 10 am to be specific) that it has received tentative approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Palbociclib capsules, 75 mg, 100 mg, and 125 mg. 

Blue Star Limited is experiencing a gradual increase in the inflow of orders for bundled services. Presently, this order is one of the largest and fast-track projects, which is being executed by Blue Star in the factories’ segment.

The mineable reserve block is 1,091 million metric tonnes, which is to be exploited for a period of 25 years at a peak rated capacity of 50 million tonnes per annum.

On the volumes’ front, the company reported the highest-ever quarterly sales volume in Q2FY21. Besides, it registered a significant jump of 60.71 per cent QoQ to 61,224 MT in Q2FY21 vs 38,096 in Q1FY21.

Biocon Ltd announced that the board of its subsidiary, Biocon Biologics Ltd has approved a capital injection of Rs 1,125 crore from Goldman Sachs on Saturday. Under the terms of the agreement, Goldman Sachs will be issued optionally convertible debentures at a post-money equity valuation of USD 3.94 billion.

The market opened in green on November 09, 2020.

The market opened in green on November 09, 2020, overall volumes in futures & options currently stand at 1,90,93,884 contracts with a turnover of Rs. 14,51,060.02 crore.

The market opened in green on November 09, 2020, overall volumes in futures & options currently stand at 1,90,93,884 contracts with a turnover of Rs. 14,51,060.02 crore.

Gland Pharma, a pharmaceutical company focussed on generic injectables, is hitting the primary capital market with its IPO today. Read on to find out if you should subscribe to the issue.

Adani Group announced a strategic collaboration with Italy-based Snam, Europe’s leading gas infrastructure company, on Friday.